FDA Pushes to Increase the Development of Abuse-Deterrent Opioids
The US Food and Drug Administration (FDA) is working hard to make sure that generic versions of abuse-deterrent opioids are just as deterrent as the…
Drug Addiction
PRESS RELEASE: Potential for Misuse & Diversion of Opioids to Addicts Should Not Overshadow Their Therapeutic Value
The following public release announcement was issued by the Journal of Palliative Medicine and its publisher, Mary Ann Liebert, Inc.: Opioids are very effective for…
Opinion: Opioid Caused Deaths – What We Can Learn
By Paul Gileno - President/US Pain Foundation Hearing of more deaths today from medication overdose saddens me. When will these tragedies stop? Lives are ended…
CDC Says Don’t Test Opioid Users for Marijuana
SFGATE.com reports the CDC is discouraging testing chronic pain sufferers for THC. The Hearst-owned website, which is a sister-site of the San Francisco Chronicle, published…
Opinion: Pain and Opioid Use Among Seniors – Issues and Emerging Trends
By Sean Mackey, M.D., Ph.D. Editor’s Note: Sean Mackey, M.D., Ph.D., is Chief of the Division of Pain Medicine at Stanford University. Our country has…
AMA Chief Adds Voice to Opioid Debate
By Ed Coghlan The president of the American Medical Association has added his voice to the national discussion on the use of opioid medication. The…
Medication with Lower Abuse Potential Now Available
By Ed Coghlan As federal scrutiny over opioid abuse continues to accelerate, news this week that an alternative is commercially available. BioDelivery Sciences International, Inc.…
Reaction to New Massachusetts Medical School Curriculum Aimed at Stemming Explosive Rise in Opioid Misuse
By Ed Coghlan In an effort to address the opioid overdose crisis in Massachusetts, Governor Charlie Baker reached out last falls to the deans of…